1. An M, Gao Y. Urinary biomarkers of brain diseases. Genomics Proteomics Bioinformatics. 2015;13(6):345–54.
https://doi.org/10.1016/j.gpb.2015.08.005
.
2. Bensalma S, Chadeneau C, Legigan T, Renoux B, Gaillard A, de Boisvilliers M, Pinet-Charvet C, Papot S, Muller JM. Evaluation of cytotoxic properties of a cyclopamine glucuronide prodrug in rat glioblastoma cells and tumors. J Mol Neurosci. 2015;55(1):51–61.
https://doi.org/10.1007/s12031-014-0395-3
.
3. Cheng YX, Li F, Lu JY, Li M, Du P, Xu GL, Feng H. Growth of G422 glioma implanted in the mouse brain was affected by the immune ability of the host. Chin Med J. 2011;124(13):1994–8.
4. Doan NB, Nguyen HS, Montoure A, Al-Gizawiy MM, Mueller WM, Kurpad S, Rand SD, Connelly JM, Chitambar CR, Schmainda KM, Mirza SP. Acid ceramidase is a novel drug target for pediatric brain tumors. Oncotarget. 2017;8(15):24753–61.
https://doi.org/10.18632/oncotarget.15800
.
5. Gao Y. Urine-an untapped goldmine for biomarker discovery? Sci China Life Sci. 2013;56(12):1145–6.
https://doi.org/10.1007/s11427-013-4574-1
.